Table 3.
Subject number | Subgroup | Eye | Baseline outer retina thickness | Follow-up outer retina thickness | Change in outer retina thickness | Length of follow-up (months) |
---|---|---|---|---|---|---|
1 | Probable tauopathy | OS | 144.7 | 142.9 | −1.8 | 12 |
2 | Probable tauopathy | OD | 108.8 | 109.4 | 0.6 | 11 |
OS | 120.8 | 118.0 | −2.8 | 11 | ||
3 | Probable tauopathy | OD | 143.2 | 145.1 | 1.9 | 13 |
OS | 143.9 | 147.7 | 3.9 | 13 | ||
4 | Probable tauopathy | OD | 130.2 | 127.0 | −3.2 | 19 |
OS | 132.9 | 123.8 | −9.1 | 19 | ||
5 | Probable tauopathy | OD | 129.1 | 115.3 | −13.7 | 18 |
OS | 130.5 | 127.2 | −3.3 | 18 | ||
6 | Probable tauopathy | OD | 140.6 | 136.6 | −4.0 | 14 |
OS | 143.7 | 142.5 | −1.2 | 14 | ||
7 | Probable tauopathy | OD | 140.7 | 127.4 | −13.3 | 12 |
OS | 124.1 | 125.3 | 1.2 | 12 | ||
8 | Probable tauopathy | OS | 150.5 | 151.7 | 1.2 | 12 |
9 | Probable tauopathy | OD | 141.8 | 122.0 | −19.8 | 24 |
OS | 136.8 | 121.2 | −15.6 | 24 | ||
10 | Probable TDP | OD | 123.4 | 146.5 | 23.1 | 12 |
OS | 117.1 | 124.3 | 7.2 | 12 | ||
11 | Probable TDP | OD | 124.5 | 136.6 | 12.1 | 24 |
OS | 142.1 | 140.5 | −1.6 | 24 | ||
12 | Unknown pathology | OD | 151.2 | 152.6 | 1.4 | 12 |
OS | 137.0 | 149.4 | 12.4 | 12 | ||
13 | Unknown pathology | OD | 122.8 | 133.0 | 10.3 | 21 |
OS | 137.8 | 118.4 | −19.4 | 21 | ||
14 | Unknown pathology | OD | 128.5 | 125.3 | −3.2 | 13 |
OS | 142.5 | 130.2 | −12.2 | 13 | ||
15 | Unknown pathology | OD | 137.8 | 130.1 | −7.7 | 18 |
OS | 140.5 | 141.5 | 1.0 | 18 | ||
16 | Unknown pathology | OD | 133.4 | 130.7 | −2.8 | 12 |
OS | 134.7 | 136.3 | 1.5 | 12 |
TDP, TAR DNA binding protein.